These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 9750252)

  • 41. The beta-blocker heart attack trial. beta-Blocker Heart Attack Study Group.
    JAMA; 1981 Nov; 246(18):2073-4. PubMed ID: 7026815
    [TBL] [Abstract][Full Text] [Related]  

  • 42. An additive boundary for group sequential designs with connection to conditional error.
    Xi D; Gallo P
    Stat Med; 2019 Oct; 38(23):4656-4669. PubMed ID: 31338847
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Group sequential large sample T2-like chi2 tests for multivariate observations.
    Lachin JM; Greenhouse SW; Bautista OM
    Stat Med; 2003 Nov; 22(21):3357-68. PubMed ID: 14566920
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Fitting spending functions.
    Anderson KM; Clark JB
    Stat Med; 2010 Feb; 29(3):321-7. PubMed ID: 19842091
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Controlled randomized clinical trials].
    Jaillon P
    Bull Acad Natl Med; 2007; 191(4-5):739-56; discussion 756-8. PubMed ID: 18225427
    [TBL] [Abstract][Full Text] [Related]  

  • 46. A general statistical principle for changing a design any time during the course of a trial.
    Müller HH; Schäfer H
    Stat Med; 2004 Aug; 23(16):2497-508. PubMed ID: 15287080
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Does tight heart rate control improve beta-blocker efficacy? An updated analysis of the noncardiac surgical randomized trials.
    Beattie WS; Wijeysundera DN; Karkouti K; McCluskey S; Tait G
    Anesth Analg; 2008 Apr; 106(4):1039-48, table of contents. PubMed ID: 18349171
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Adaptive designs with correlated test statistics.
    Götte H; Hommel G; Faldum A
    Stat Med; 2009 May; 28(10):1429-44. PubMed ID: 19226563
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Early stopping to accept H(o) based on conditional power: approximations and comparisons.
    Betensky RA
    Biometrics; 1997 Sep; 53(3):794-806. PubMed ID: 9290216
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [The use of state of the art statistical methodology in biomedical research: the example of methodology for interim analyses in clinical trials].
    Muñoz SR; Bangdiwala SI
    Rev Med Chil; 2001 Sep; 129(9):983-8. PubMed ID: 11725478
    [TBL] [Abstract][Full Text] [Related]  

  • 51. beta-adrenergic receptor blockers and the treatment of vasovagal syncope: more nails in the coffin!
    Mathias CJ
    Clin Sci (Lond); 2006 Sep; 111(3):189-91. PubMed ID: 16848762
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Mixtures of prior distributions for predictive Bayesian sample size calculations in clinical trials.
    Brutti P; De Santis F; Gubbiotti S
    Stat Med; 2009 Jul; 28(17):2185-201. PubMed ID: 19462415
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Assessment of futility in clinical trials.
    Snapinn S; Chen MG; Jiang Q; Koutsoukos T
    Pharm Stat; 2006; 5(4):273-81. PubMed ID: 17128426
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Post-myocardial infarction beta-blocker therapy: the bradycardia conundrum. Rationale and design for the Pacemaker & beta-blocker therapy post-MI (PACE-MI) trial.
    Goldberger JJ; Bonow RO; Cuffe M; Dyer A; Greenland P; Rosenberg Y; O'Rourke R; Shah PK; Smith S
    Am Heart J; 2008 Mar; 155(3):455-64. PubMed ID: 18294477
    [TBL] [Abstract][Full Text] [Related]  

  • 55. A method for sequential analysis of survival data with nonproportional hazards.
    Sooriyarachchi MR; Whitehead J
    Biometrics; 1998 Sep; 54(3):1072-84. PubMed ID: 9750253
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Statistical aspects of early termination in the beta-blocker heart attack trial.
    DeMets DL; Hardy R; Friedman LM; Lan KK
    Control Clin Trials; 1984 Dec; 5(4):362-72. PubMed ID: 6151482
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Stopping clinical trials early for benefit: impact on estimation.
    Freidlin B; Korn EL
    Clin Trials; 2009 Apr; 6(2):119-25. PubMed ID: 19342463
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Efficient group sequential designs when there are several effect sizes under consideration.
    Jennison C; Turnbull BW
    Stat Med; 2006 Mar; 25(6):917-32. PubMed ID: 16220524
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Bootstrap analysis of multivariate failure time data.
    Monaco J; Cai J; Grizzle J
    Stat Med; 2005 Nov; 24(22):3387-400. PubMed ID: 16237657
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Influence of beta-blockers on the outcome of at risk patients.
    Priebe HJ
    Minerva Anestesiol; 2009 May; 75(5):319-23. PubMed ID: 19412151
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.